BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RNDP-001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RNDP-001\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07106021-1668@assetmemo.bio
DTSTAMP:20261121T005730Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:RNDP-001: Phase 1/2 readout est. (NCT07106021)
DESCRIPTION:RNDP-001\, phase 1/2\, Parkinson's Disease.\nStudy: A Study to 
 Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients Wit
 h Idiopathic Parkinson's Disease\nEstimated primary completion: September 
 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout date
 \, and it can move.\nDrug page: https://assetmemo.bio/drug/rndp-001#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT07106021
URL:https://assetmemo.bio/drug/rndp-001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
